Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
109 hedge funds and large institutions have $1.06B invested in Epizyme, Inc in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 14 closing their positions.
64% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 14
42% more capital invested
Capital invested by funds: $749M → $1.06B (+$316M)
27% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 30
24% more call options, than puts
Call options by funds: $1.17M | Put options by funds: $947K
8% more funds holding
Funds holding: 101 → 109 (+8)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.6M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.81M |
| 3 |
Jennison Associates
New York
|
+$4.6M |
| 4 |
JP Morgan Chase
New York
|
+$3.12M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$2.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$6.75M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.51M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.49M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.92M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.48M |
EPZM Hedge Fund Activity: Q1 2018 in Review
109 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q1 2018, worth a combined $1.06B — up 42% from $749M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new EPZM positions and 14 closed out — a net gain of 9 holders — while 38 added to existing stakes and 30 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $10.6M. The largest seller was Norges Bank, cutting an estimated $6.75M.
- 109 institutional investors held Epizyme, Inc (EPZM) as of Q1 2018, up from 101 in Q4 2017.
- Funds reported $1.06B of Epizyme, Inc stock for Q1 2018, up 42% quarter-over-quarter.
- 23 funds opened new Epizyme, Inc positions in Q1 2018 and 14 closed out, a net change of +9 holders.
- The largest Epizyme, Inc buyer in Q1 2018 was Point72 Asset Management, an estimated $10.6M added.
- The largest Epizyme, Inc seller in Q1 2018 was Norges Bank, an estimated $6.75M sold.
Based on aggregated 13F filings for Q1 2018.